Related Experiment Videos

GDNF treatment in Parkinson's disease: time for controlled clinical trials?

Brain : a Journal of Neurology

|September 24, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Targeting DNA mismatch repair in Huntington's disease.

Trends in neurosciences·2026

Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study.

Lancet (London, England)·2026

Genome-wide DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction.

Clinical epigenetics·2026

Aggregation-prone alpha-synuclein proteoforms and dysregulated molecular signatures in the vermiform appendix of synucleinopathy patients.

bioRxiv : the preprint server for biology·2025

Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology.

Acta neuropathologica communications·2025

Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse model.

Journal of Parkinson's disease·2025

See all related articles